Phase I Study to Assess the Histologic Effect and Safety of Pre-Operative and Post-Operative Infusions of IL13-PE38QQR Cytotoxin in Patients With Recurrent Resectable Supratentorial Malignant Glioma
Phase of Trial: Phase I
Latest Information Update: 25 Jun 2013
At a glance
- Drugs Cintredekin besudotox (Primary)
- Indications Anaplastic astrocytoma; Astrocytoma; Glioblastoma; Glioma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 14 Jun 2013 New source identified and integrated (M.D. Anderson Cancer Center: NS01-127).
- 22 Dec 2009 Actual end date (Jan 2005) added as reported by ClinicalTrials.gov.